In the landscape of HIV treatment, antiretroviral therapy (ART) has long been hailed as a transformative intervention, enabling millions of…

Treeline Biosciences, a well-funded cancer company that has raised more than $1 billion since its 2021 founding, is looking to…

In a groundbreaking development poised to reshape the future of wearable electronics, researchers at Seoul National University (SNU) have unveiled…

In a groundbreaking study that redefines our understanding of sleep and its neural mechanics, scientists funded by the National Institutes…

In an era where food allergies and immune system conundrums are increasingly impacting pediatric health worldwide, the identification of precise…

Johnson & Johnson has paid $1 billion upfront to buy itself a degrader antibody conjugate (DAC) platform via the acquisition…

Incyte has struck a deal to buy a Star Therapeutics subsidiary for $1.25 billion upfront. The takeover, the biggest bet of…

GSK’s latest hepatology partnership is posing a less-asked question—how do you encourage the regression of patients’ liver fibrosis? To find…

The intricate interplay between physical health and cognitive development has long been a subject of scientific scrutiny, but a groundbreaking…